Literature DB >> 408003

Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.

P H Gutin, J A Levi, P H Wiernik, M D Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 408003

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  18 in total

Review 1.  Current options for the treatment of neoplastic meningitis.

Authors:  Ilkcan Cokgor; Allan H Friedman; Henry S Friedman
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

2.  Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats.

Authors:  C Bethune; A Blum; J R Geyer; J R Silber; R J Ho
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

3.  Cytostatic treatment of meningeal blastoses.

Authors:  P Engelhardt; R Lorenz
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

4.  Intrathecal chemotherapy with MX2 for treating glioma dissemination in vivo.

Authors:  S Mizumatsu; K Matsumoto; Y Ono; T Tamiya; T Furuta; T Ohmoto
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

5.  Mechanisms and kinetics of thiotepa and tepa hydrolysis: DFT study.

Authors:  Hedieh Torabifard; Alireza Fattahi
Journal:  J Mol Model       Date:  2012-02-14       Impact factor: 1.810

6.  Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.

Authors:  V A Levin; M Chamberlain; P Silver; L Rodriguez; M Prados
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa.

Authors:  A Comte; W Jdid; M N Guilhaume; I Kriegel; S Piperno-Neumann; V Dieras; T Dorval; J Y Pierga; P H Cottu; L Mignot; F C Bidard
Journal:  J Neurooncol       Date:  2013-09-17       Impact factor: 4.130

8.  Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.

Authors:  M Kochi; S Takaki; J Kuratsu; H Seto; I Kitamura; Y Ushio
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Emergencies in oncology. Current management.

Authors:  D C Stolinsky
Journal:  West J Med       Date:  1978-09

10.  Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.

Authors:  Y Ushio; M Kochi; I Kitamura; J Kuratsu
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.